Cochrane Abstracts
Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Haloperidol Versus Low-potency First-generation Antipsychotic Drugs for Schizophrenia: Cochrane Systematic Review." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435215/all/Haloperidol_versus_low_potency_first_generation_antipsychotic_drugs_for_schizophrenia:_Cochrane_systematic_review.
Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia: Cochrane systematic review. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435215/all/Haloperidol_versus_low_potency_first_generation_antipsychotic_drugs_for_schizophrenia:_Cochrane_systematic_review. Accessed January 17, 2025.
Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia: Cochrane systematic review. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435215/all/Haloperidol_versus_low_potency_first_generation_antipsychotic_drugs_for_schizophrenia:_Cochrane_systematic_review
Haloperidol Versus Low-potency First-generation Antipsychotic Drugs for Schizophrenia: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 17]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435215/all/Haloperidol_versus_low_potency_first_generation_antipsychotic_drugs_for_schizophrenia:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia: Cochrane systematic review
ID - 435215
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435215/all/Haloperidol_versus_low_potency_first_generation_antipsychotic_drugs_for_schizophrenia:_Cochrane_systematic_review
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
